Evolving P450pyr hydroxylase for highly enantioselective hydroxylation at non-activated carbon atom.

Directed evolution of a monooxygenase to achieve very high enantioselectivity for hydroxylation at non-activated carbon atoms is demonstrated for the first time, where a triple mutant of P450pyr hydroxylase is obtained via determination of enzyme structure, iterative saturation mutagenesis, and high-throughput screening with a MS-based ee assay to increase the product ee from 53% to 98% for the hydroxylation of N-benzyl pyrrolidine to (S)-N-benzyl 3-hydroxypyrrolidine.

[1]  Weng Lin Tang,et al.  Regio‐ and Stereoselective Biohydroxylations with a Recombinant Escherichia coli Expressing P450pyr Monooxygenase of Sphingomonas Sp. HXN‐200 , 2010 .

[2]  Manfred T Reetz,et al.  Regio- and stereoselectivity of P450-catalysed hydroxylation of steroids controlled by laboratory evolution , 2011, Nature Chemistry.

[3]  B. Witholt,et al.  Preparation of (S)-N-substituted 4-hydroxy-pyrrolidin-2-ones by regio- and stereoselective hydroxylation with Sphingomonas sp. HXN-200. , 2000, Organic letters.

[4]  S. Katakura,et al.  Dibasic (amidinoaryl)propanoic acid derivatives as novel blood coagulation factor Xa inhibitors. , 1994, Journal of medicinal chemistry.

[5]  B. Witholt,et al.  Regio- and stereoselective hydroxylation of N-substituted piperidin-2-ones with Sphingomonas sp. HXN-200 , 2002 .

[6]  F. Arnold,et al.  Enantioselective alpha-hydroxylation of 2-arylacetic acid derivatives and buspirone catalyzed by engineered cytochrome P450 BM-3. , 2006, Journal of the American Chemical Society.

[7]  N. Turner,et al.  Directed Evolution of Galactose Oxidase: Generation of Enantioselective Secondary Alcohol Oxidases , 2008, Chembiochem : a European journal of chemical biology.

[8]  Frances H. Arnold,et al.  Laboratory evolution of a soluble, self-sufficient, highly active alkane hydroxylase , 2002, Nature Biotechnology.

[9]  B. Witholt,et al.  Practical syntheses of N-substituted 3-hydroxyazetidines and 4-hydroxypiperidines by hydroxylation with Sphingomonas sp. HXN-200. , 2002, Organic letters.

[10]  J. Kingma,et al.  Substrate specificity of the alkane hydroxylase system of Pseudomonas oleovorans GPo1 , 1994 .

[11]  Manfred T Reetz,et al.  Laboratory evolution of stereoselective enzymes: a prolific source of catalysts for asymmetric reactions. , 2011, Angewandte Chemie.

[12]  Maarten Merkx,et al.  Dioxygen Activation and Methane Hydroxylation by Soluble Methane Monooxygenase: A Tale of Two Irons and Three Proteins. , 2001, Angewandte Chemie.

[13]  M. Reetz,et al.  Laboratory evolution of robust and enantioselective Baeyer-Villiger monooxygenases for asymmetric catalysis. , 2009, Journal of the American Chemical Society.

[14]  A. Munro,et al.  Variations on a (t)heme--novel mechanisms, redox partners and catalytic functions in the cytochrome P450 superfamily. , 2007, Natural product reports.

[15]  Young-Tae Lee,et al.  P450cam visits an open conformation in the absence of substrate. , 2010, Biochemistry.

[16]  A. Schmid,et al.  Oxidative biotransformations using oxygenases. , 2002, Current opinion in chemical biology.

[17]  F. Arnold,et al.  Stereoselective hydroxylation of an achiral cyclopentanecarboxylic acid derivative using engineered P450s BM-3. , 2005, Chemical communications.

[18]  John C Whitman,et al.  Improving catalytic function by ProSAR-driven enzyme evolution , 2007, Nature Biotechnology.

[19]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[20]  B. Witholt,et al.  Preparation of optically active N-benzyl-3-hydroxypyrrolidine by enzymatic hydroxylation , 1999 .

[21]  Preparation of (R)- and (S)-N-protected 3-hydroxypyrrolidines by hydroxylation with Sphingomonas sp. HXN-200, a highly active, regio- and stereoselective, and easy to handle biocatalyst. , 2001, The Journal of organic chemistry.

[22]  Nicholas J Turner,et al.  Directed evolution of an amine oxidase possessing both broad substrate specificity and high enantioselectivity. , 2003, Angewandte Chemie.

[23]  Nicholas J Turner,et al.  Directed evolution drives the next generation of biocatalysts. , 2009, Nature chemical biology.

[24]  Frances H Arnold,et al.  Regio- and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3. , 2003, Journal of the American Chemical Society.

[25]  Frances H. Arnold,et al.  Inverting enantioselectivity by directed evolution of hydantoinase for improved production of l-methionine , 2000, Nature Biotechnology.

[26]  Huimin Zhao,et al.  Inverting the enantioselectivity of P450pyr monooxygenase by directed evolution. , 2010, Chemical communications.

[27]  M. J. Coon,et al.  Characterization of the ω-hydroxylase of Pseudomonas oleovorans as a nonheme iron protein , 1977 .

[28]  Weng Lin Tang,et al.  High-throughput method for determining the enantioselectivity of enzyme-catalyzed hydroxylations based on mass spectrometry. , 2010, Angewandte Chemie.

[29]  M. Terai,et al.  Stereoselectivity of a potent calcium antagonist, 1-benzyl-3-pyrrolidinyl methyl 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate. , 1986, Journal of medicinal chemistry.

[30]  Zhixiang Chang.  Recent Advances in Regio- and Stereoselective Biohydroxylation of Non- Activated Carbon Atoms , 2004 .

[31]  Frances H Arnold,et al.  Cytochrome P450: taming a wild type enzyme. , 2011, Current opinion in biotechnology.